Induction chemotherapy in locally advanced squamous cell carcinoma of the head and neck: role, controversy, and future directions

par Haddad, R I, Posner, M, Hitt, R, Cohen, E E W, Schulten, J, Lefebvre, J -L, Vermorken, J B
Publié dans Ann Oncol (2018)

Survival and human papillomavirus in oropharynx cancer in TAX 324: a subset analysis from an international phase III trial

par Posner, M. R., Lorch, J. H., Goloubeva, O., Tan, M., Schumaker, L. M., Sarlis, N. J., Haddad, R. I., Cullen, K. J.
Publié dans Ann Oncol (2011)

Afatinib versus methotrexate in older patients with second-line recurrent and/or metastatic head and neck squamous cell carcinoma: subgroup analysis of the LUX-Head & Neck 1 trial(...

par Clement, P. M., Gauler, T., Machiels, J. P., Haddad, R. I., Fayette, J., Licitra, L. F., Tahara, M., Cohen, E. E. W., Cupissol, D., Grau, J. J., Guigay, J., Caponigro, F., de Castro, G., de Souza Viana, L., Keilholz, U., del Campo, J. M., Cong, X. J., Ehrnrooth, E., Vermorken, J. B.
Publié dans Ann Oncol (2016)

Weekly paclitaxel, carboplatin, cetuximab, and cetuximab, docetaxel, cisplatin, and fluorouracil, followed by local therapy in previously untreated, locally advanced head and neck...

par Haddad, R.I., Massarelli, E., Lee, J.J., Lin, H.Y., Hutcheson, K., Lewis, J., Garden, A.S., Blumenschein, G.R., William, W.N., Pharaon, R.R., Tishler, R.B., Glisson, B.S., Pickering, C., Gold, K.A., Johnson, F.M., Rabinowits, G., Ginsberg, L.E., Williams, M.D., Myers, J., Kies, M.S., Papadimitrakopoulou, V.
Publié dans Ann Oncol (2019)

The role of oral hygiene in head and neck cancer: results from International Head and Neck Cancer Epidemiology (INHANCE) consortium

par Hashim, D., Sartori, S., Brennan, P., Curado, M. P., Wünsch-Filho, V., Divaris, K., Olshan, A. F., Zevallos, J. P., Winn, D. M., Franceschi, S., Castellsagué, X., Lissowska, J., Rudnai, P., Matsuo, K., Morgenstern, H., Chen, C., Vaughan, T. L., Hofmann, J. N., D'Souza, G., Haddad, R. I., Wu, H., Lee, Y.-C., Hashibe, M., Vecchia, C. La, Boffetta, P.
Publié dans Ann Oncol (2016)

Biomarkers predict enhanced clinical outcomes with afatinib versus methotrexate in patients with second-line recurrent and/or metastatic head and neck cancer

par Cohen, E. E. W., Licitra, L. F., Burtness, B., Fayette, J., Gauler, T., Clement, P. M., Grau, J. J., del Campo, J. M., Mailliez, A., Haddad, R. I., Vermorken, J. B., Tahara, M., Guigay, J., Geoffrois, L., Merlano, M. C., Dupuis, N., Krämer, N., Cong, X. J., Gibson, N., Solca, F., Ehrnrooth, E., Machiels, J.-P. H.
Publié dans Ann Oncol (2017)